Scott Durbin - Jan 3, 2023 Form 4 Insider Report for VIVEVE MEDICAL, INC. (VIVE)

Role
Chief Executive Officer, Director
Signature
/s/ Scott Durbin
Stock symbol
VIVE
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 03:03 PM
Previous filing
Jan 6, 2022
Next filing
Sep 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVE Restricted Stock Unit Award $0 +360K $0.00 360K Jan 3, 2023 Common Stock 360K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock.
F2 The RSUs vest in full on the earlier of December 1, 2023 or the closing of a Sale Event (as defined in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan), subject to the reporting person's continuous service to the Issuer.